Binge Eating Disorder

Current Binge Eating Disorder News & Information

0

TOS announces FDA approval of new prescription drug for treating binge eating ... - News-Medical.net

TOS announces FDA approval of new prescription drug for treating binge eating …News-Medical.netThe United States Food and Drug Administration (FDA) recently approved lisdexamfetamine dimesylate, under the brand name Vyvanse, to treat moderate to severe binge eating disorder (BED) in adults, a first of its kind prescription drug specifically … <a target="_blank" …read more

0

Vyvanse Approved for Binge-Eating Disorder - WebMD

WebMDVyvanse’s safety and effectiveness in treating binge-eating disorder were evaluated in clinical studies involving 724 people. A central nervous system stimulant, Vyvanse could cause serious complications including stroke and heart attack. It also could …Shire’s Vyvanse Label Expanded for Binge-Eating Disorder – Analyst BlogNasdaqFDA Approves New Drug for …read more

0

Shire's Vyvanse Label Expanded for Binge-Eating Disorder - Analyst Blog - Nasdaq

Shire’s Vyvanse Label Expanded for Binge-Eating Disorder – Analyst BlogNasdaqreceived positive news with the FDA expanding Vyvanse’s label for the treatment of moderate to severe binge eating disorder (B.E.D.) in adults. Approval makes Vyvanse the first and only FDA-approved treatment for this disorder. We note that Vyvanse is … <a target="_blank" …read more

0

Clearing your mind through meditation could reduce binge eating - KCTV Kansas City

Clearing your mind through meditation could reduce binge eatingKCTV Kansas City… some research suggests meditation increases awareness, allowing for more mindful eating. Yogi Malory Ward told KCTV5 her appetite decreased since she started meditation during Bikram yoga. “I used to have problems with binge eating and I don’t … <a target="_blank" …read more

0

Shire hyperactivity drug approved as treatment for binge-eating - Telegraph.co.uk

Telegraph.co.ukAmerica’s medicines regulator the Food and Drug Administration (FDA) announced over the weekend that Vyvanse, which is currently used to treat ADHD in children and adults, had become the first approved treatment for binge-eating disorder (BED).FDA approves an ADHD drug as treatment for binge-eating disorderGlobalnews.caFDA expands uses of …read more

0

Shire gets FDA nod for first binge-eating treatment - PMLiVE

Shire gets FDA nod for first binge-eating treatmentPMLiVE“Binge eating disorder is not just about eating a lot; it is that, plus being out of control and feeling bad about it,” according to Perry Sternberg, head of Shire’s neuroscience business unit, who notes it is the most common adult eating …read more

0

BRIEF-Shire says Vyvanse approved for binge eating treatment in US - Reuters

BRIEF-Shire says Vyvanse approved for binge eating treatment in USReutersFeb 2 (Reuters) – Shire Plc. * vyvanse (lisdexamfetamine dimesylate) capsules (cii) becomes first and only treatment approved by fda for adults with moderate to severe binge eating Source text for Eikon: Further company coverage: (Reporting By Sarah … …read more

0

FDA Approves ADHD Drug for Binge-Eating Disorder - Memphis Daily News

FDA Approves ADHD Drug for Binge-Eating DisorderMemphis Daily NewsWASHINGTON (AP) – Federal health regulators have approved an attention deficit disorder drug for a new use: A first-of-its kind treatment for binge-eating disorder. About 2 percent of U.S. adults, or about 5 million people, have binge eating disorder, … …read more

0

Neural Circuit May Control Binge Eating - MedPage Today

MedPage TodayNote that this mouse study demonstrated that a specific hypothalamic circuit may be responsible for compulsive overeating. Be aware that deactivating this circuit reduced compulsive eating, but did not affect appetite, suggesting that the mechanisms … …read more

0

Shire gets go ahead to market binge-eating medicine - Financial Times

Financial TimesShire has received its second important regulatory breakthrough in two weeks after winning US approval for the first medicine to treat binge-eating disorder. The UK-listed drugmaker received a go-ahead from the US Food and Drug Administration to market … …read more

1 263 264 265 266 267 279